Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8435-8440

  Dittmer, Ulf ^a,b   Race, Brent ^a   Hasenkrug, Kim J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Inst fur Virologie/Immunbiologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FRIEND LEUKEMIA VIRUS; HELPER CELL; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIRUS INFECTION;

EID: 0032875343     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8435-8440.1999     Document Type: Article

References (38)

1. Baba, T. W., V. Liska, A. H. Khimani, N. B. Ray, P. J. Dailey, D. Penninck, R. Bronson, M. F. Greene, H. M. McClure, L. N. Martin, and R. M. Ruprecht. 1999. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5:194-203.
2. Chesebro, B., W. Britt, L. Evans, K. Wehrly, J. Nishlo, and M. Cloyd. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
3. Chesebro, B., M. Miyazawa, and W. J. Britt. 1990. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8:477-499.
4. Chesebro, B., K. Wehrly, and J. Stimpfling. 1974. Host genetic control of recovery from Friend leukemia virus-induced splenomegaly. Mapping of a gene within the major histocompatibility complex. J. Exp. Med. 140:1457-1467.
5. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (London) 312:548-551.
6. Connor, R. I., D. C. Montefiori, J. M. Binley, J. P. Moore, S. Bonhoeffer, A. Gettie, E. A. Fenamore, K. E. Sheridan, D. D. Ho, P. J. Dailey, and P. A. Marx. 1998. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72:7501-7509.
7. Dittmer, U., D. M. Brooks, and K. J. Hasenkrug. 1998. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. J. Virol. 72:6554-6558.
8. Dittmer, U., D. M. Brooks, and K. J. Hasenkrug. 1999. Protection against establishment of retroviral persistence by vaccination with a live attenuated virus. J. Virol. 73:3753-3757.
9. Dittmer, U., D. M. Brooks, and K. J. Hasenkrug. 1999. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection. Nat. Med. 5:189-193.
10. Dittmer, U., and K. J. Hasenkrug. 1999. Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines. AIDS Res. Hum. Retroviruses 15:785. (Letter.)
11. Dittmer, U., T. Nisslein, W. Bodemer, H. Petry, U. Sauermann, C. Stahl-Hennig, and G. Hunsmann. 1995. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392-397.
12. Dyer, W. B., G. S. Ogg, M. A. Demoitie, X. Jin, A. F. Geczy, S. L. Rowland-Jones, A. J. McMichael, D. F. Nixon, and J. S. Sullivan. 1999. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J. Virol. 73:436-443.
13. Earl, P. L., B. Moss, R. P. Morrison, K. Wehrly, J. Nishio, and B. Chesebro. 1986. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234:728-731.
14. Gauduin, M. C., P. W. Parren, R. Weir, C. F. Barbas, D. R. Burton, and R. A. Koup. 1997. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat. Med. 3:1389-1393.
15. Hasenkrug, K. J., D. M. Brooks, and B. Chesebro. 1995. Passive immuno-therapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc. Natl. Acad. Sci. USA 92:10492-10495.
16. Hasenkrug, K. J., D. M. Brooks, and U. Dittmer. 1998. Critical role for CD4* T cells in controlling retrovirus replication and spread in persistently infected mice. J. Virol. 72:6559-6564.
17. Hasenkrug, K. J., D. M. Brooks, J. Nishio, and B. Chesebro. 1996. Differing T-cell requirements for recombinant retrovirus vaccines. J. Virol. 70:368-372.
18. Hasenkrug, K. J., D. M. Brooks, M. N. Robertson, R. V. Srinlvas, and B. Chesebro. 1998. Immunoprotective determinants in Friend murine leukemia virus envelope protein. Virology 248:66-73.
19. Hasenkrug, K. J., and B. Chesebro. 1997. Immunity to retroviral infection: the Friend virus model. Proc. Natl. Acad. Sci. USA 94:7811-7816.
20. Hislop, A. D., M. F. Good, L. Mateo, J. Gardner, M. H. Gatei, R. C. Daniel, B. V. Meyers, M. F. Lavin, and A. Suhrbier. 1998. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge. Nat. Med. 4:1193-1196.
21. Hoatlin, M. E, and D. Kabat. 1995. Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol. 3:51-57.
22. Igarashi, T., C. Brown, A. Azadegan, N. Haigwood, D. Dimitrov, M. A. Martin, and R. Shibata. 1999. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat. Med. 5:211-216.
23. Johnson, P. 1999. Live attenuated AIDS vaccines: hazards and hopes. Nat. Med. 5:154-155.
24. Kabal, D. 1989. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 148:1-42.
25. Lander, M. R., and S. K. Chattopadhyay. 1984. A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J. Virol. 52:695-698.
26. Li, J.-P., A. D. D'Andre, H. F. Lodish, and D. Baltimore. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (London) 343:762-764.
27. Lilly, F. 1967. Susceptibility to two strains of Friend leukemia virus in mice. Science 155:461-462.
28. Moore, J. P., and D. R. Burton. 1999. HIV-1 neutralizing antibodies: how full is the bottle? Nat. Med. 5:142-144.
29. Moreau-Gachelin, F., A. Tavitian, and P. Tambourin. 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukemia. Nature (London) 331:277-280.
30. Morrison, R. P., P. L. Earl, J. Nishio, D. L Lodmell, B. Moss, and B. Chesebro. 1987. Different H-2 subregions influence immunization against retrovirus and immunosuppression. Nature (London) 329:729-732.
31. Munroe, D. G., J. W. Peacock, and S. Benchimol. 1990. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell. Biol. 10:3307-3313.
32. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825-833.
33. Robertson, M. N., M. Miyazawa, S. Mori, B. Caughey, L. H. Evans, S. F. Hayes, and B. Chesebro. 1991. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J. Virol. Methods 34:255-271.
34. Ruprecht, R. M., S. Ayehunie, T. W. Baba, L. An, V. Liska, D. Penninck, M. Greene, and D. C. Montefiori. 1995. SIV pathogenesis during ontogeny - the virus threshold hypothesis. AIDS Res. Hum. Retroviruses 11:S129.
35. Shibata, R., T. Igarashi, N. Haigwood, A. Buckler-White, R. Ogert, W. Ross, R. Wllley, M. W. Cho, and M. A. Martin. 1999. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5:204-210.
36. Sitbon, M., J. Nishio, K. Wehrly, D. Lodmell, and B. Chesebro. 1985. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses. Virology 141:110-118.
37. Testi, R., D. D'Ambrosio, R. De Maria, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15:479-183.
38. Wendling, F., and P. E. Tambourin. 1978. Oncogenicity of Friend-virus-infected cells: determination of origin of spleen colonies by the H-2 antigens as genetic markers. Int. J. Cancer 22:479-486.